Fundraising Fox
Relation Rx
Miami Beach, US · Founded 2019 · 141 employees on LinkedIn · 8 known investors
Find your way into Relation Rx
Sign up to see every warm intro you have to Relation Rx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Relation Rx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.
Founders & leadership
Board
Investors · 8
How we know: a partner's Signal profile · board seat on SEC Form D · globenewswire.com · funding news · the VCSheet dataset · Not right? Tell us
How we know: Hitachi Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Magnetic Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · globenewswire.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$116.4M disclosed across 5 rounds · 2021–2025
▶$36.2MraisedDec 2025 · 5 investors · BiotechnologyRule 506(b)
- David RoblinExecutive Officer, Director
- Charles RobertsDirector
- Jason PontinDirector
- Jim MellonDirector
- Christine AylwardDirector
- Casey Benjamin SwernerExecutive Officer
- Offering amount
- $36.2M
- Amount sold
- $36.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$15MraisedDec 2024 · 1 investors · BiotechnologyRule 506(b)
- Jim MellonDirector
- David RoblinDirector
- Jason PontinDirector
- Christine AylwardDirector
- Charles RobertsDirector
- Casey Benjamin SwernerExecutive Officer
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$40.3MraisedJan 2024 · 10 investors · BiotechnologyRule 506(b)
- Christine AylwardDirector
- Jim MellonDirector
- Jason PontinDirector
- Casey SwernerExecutive Officer
- David RoblinExecutive Officer, Director
- Charles RobertsDirector
- Offering amount
- $51.7M
- Amount sold
- $40.3M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$16MraisedJun 2022 · 8 investors · BiotechnologyRule 506(b)
- CHARLES ROBERTSDirector
- CASEY BENJAMIN SWERNERExecutive Officer
- DAVID ROBLINDirector
- CHRISTINE AYLWARDDirector
- JASON PONTINDirector
- JIM MELLONDirector
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$9MraisedAug 2021 · 10 investors · BiotechnologyRule 506(b)
- DAVID ROBLINDirector
- CASEY BENJAMIN SWERNERExecutive Officer
- CHARLES ROBERTSDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Relation Rx do?
- Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.
- Who are Relation Rx's investors?
- Relation Rx's investors include DCVC (Data Collective), Hitachi Ventures, Magnetic Ventures, Raptor Group, Deerfield Management Company, Khosla Ventures, NVentures.
- How much funding has Relation Rx raised?
- Relation Rx has disclosed $116.4M raised across 5 rounds.
- Where is Relation Rx headquartered?
- Relation Rx is headquartered in Miami Beach, US.